CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.060
+0.030 (2.91%)
At close: Jan 2, 2025, 4:00 PM
1.070
+0.010 (0.94%)
After-hours: Jan 2, 2025, 5:53 PM EST
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $82.95 million as of January 2, 2025. Its market cap has decreased by -12.22% in one year.
Market Cap
82.95M
Enterprise Value
-26.38M
1-Year Change
-12.22%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has decreased from $464.70M to $82.95M, a decrease of -82.15%. That is a compound annual growth rate of -17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.13B |
| UnitedHealth Group | 465.54B |
| Novo Nordisk | 384.34B |
| Johnson & Johnson | 348.19B |
| AbbVie | 314.02B |
| Merck & Co. | 251.65B |
| AstraZeneca | 203.17B |
| Thermo Fisher Scientific | 198.99B |